Cumberland Pharmaceuticals (CPIX) Amortization - Intangibles (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Amortization - Intangibles across 17 years of filings, most recently posting $1.2 million for Q1 2026.

• Amortization - Intangibles for Q1 2026 came in at $1.2 million, up 24.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (down 7.85% YoY), and the FY2025 annual result was $4.0 million, down 15.03% from the prior year.
• Amortization - Intangibles came in at $1.2 million for Q1 2026 at Cumberland Pharmaceuticals, up from $1.0 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $4.5 million in Q4 2023 to a low of $458222.0 in Q4 2022.
• The 5-year median for Amortization - Intangibles is $1.2 million (2023), against an average of $1.4 million.
• Across the five-year window, Amortization - Intangibles soared 890.6% in 2023 and slumped 67.85% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Amortization - Intangibles stood at $458222.0 in 2022, then jumped by 890.6% to $4.5 million in 2023, then tumbled by 67.85% to $1.5 million in 2024, then sank by 30.57% to $1.0 million in 2025, then increased by 23.26% to $1.2 million in 2026.
• The last three Amortization - Intangibles figures came in at $1.2 million (Q1 2026), $1.0 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.